EnnoDC
Paris, France· Est. 2021
EnnoDC is a clinical-stage biotech company pioneering the development of first-in-class dendritic cell-targeting CD40 and antigen-specific immunotherapies for cancer and infectious diseases.
Private Company
Total funding raised: $2.5M
About
EnnoDC is a clinical-stage biotech company pioneering the development of first-in-class dendritic cell-targeting CD40 and antigen-specific immunotherapies for cancer and infectious diseases.
AntibodiesBiologics
Funding History
1Total raised:$2.5M
Seed$2.5MJun 15, 2022